IKZF1 and lymphoma: Cereblon E3–ubiquitin ligase modulators, termed CELMoDs, have anti-lymphoma activity via the degradation of the transcription factors Ikaros and Aiolos and upregulation of interferon stimulated genes, inducing tumor cell apoptosis and T/NK cell activation.